Short Description

NGS genetic DNA test detecets for variant and mutation detection in MDM2 gene for Accelerated tumor formation, susceptibility to

PreTest Information

Clinical History of Patient who is going for MDM2 Gene Accelerated tumor formation, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MDM2 Gene Accelerated tumor formation, susceptibility to NGS Genetic DNA Test gene MDM2

Detail Description

MDM2 Gene and Accelerated Tumor Formation: Understanding the Susceptibility to NGS Genetic DNA Test

The MDM2 gene is a crucial component of the body's DNA repair mechanism. It is responsible for producing a protein that helps regulate the cell cycle and prevent abnormal cell growth. However, mutations in this gene can lead to accelerated tumor formation, making it a crucial area of focus for genetic testing.

Symptoms of MDM2 Gene Mutations

MDM2 gene mutations are associated with several types of cancer, including breast, ovarian, and prostate cancer. Some of the common symptoms of MDM2 gene mutations include:

• Unexplained weight loss
• Chronic fatigue
• Persistent fever
• Unusual skin changes
• Chronic pain
• Abnormal bleeding or discharge

It is important to note that these symptoms may not necessarily indicate MDM2 gene mutations, and further testing is required for proper diagnosis.

Diagnosis of MDM2 Gene Mutations

Diagnosis of MDM2 gene mutations can be done through genetic testing. Next-Generation Sequencing (NGS) is a widely used genetic testing method that can identify mutations in the MDM2 gene. This testing method involves analyzing the DNA sequence of the patient to identify any abnormalities in the MDM2 gene.

NGS is a highly accurate and reliable method of genetic testing, with a success rate of over 99%. The cost of NGS genetic testing for MDM2 gene mutations in India is around INR 20,000.

Importance of Genetic Testing

Genetic testing is crucial for individuals with a family history of cancer or those who have been diagnosed with cancer. It can help identify genetic mutations that increase the risk of cancer, allowing for early detection and treatment.

Early detection is key to successful cancer treatment, and genetic testing can help identify cancer at an early stage when it is most treatable. It can also help identify individuals who are at high risk of developing cancer, allowing for preventive measures to be taken.

Conclusion

The MDM2 gene is a crucial area of focus for genetic testing as mutations in this gene can lead to accelerated tumor formation. NGS genetic testing is a highly accurate and reliable method of identifying mutations in the MDM2 gene, with a success rate of over 99%. It is crucial for individuals with a family history of cancer or those who have been diagnosed with cancer to undergo genetic testing to identify any genetic mutations that increase the risk of cancer.

Before getting tested ask for Raw Data, FASTQ, and VCF files along with clinical test report from DNA Testing Lab. DNA Labs India is the Only lab that is transparent and will share Raw Data, FASTQ, and VCF files along with the conclusive clinical report for MDM2 Gene Accelerated tumor formation, susceptibility to NGS Genetic DNA Test